2022-RA-1245-ESGO Correlation between false negatives of FDG-TEP staging in locally advanced cervical cancer and FIGO 2009 clinical staging system. A retrospective single-center cohort. (20th October 2022)
- Record Type:
- Journal Article
- Title:
- 2022-RA-1245-ESGO Correlation between false negatives of FDG-TEP staging in locally advanced cervical cancer and FIGO 2009 clinical staging system. A retrospective single-center cohort. (20th October 2022)
- Main Title:
- 2022-RA-1245-ESGO Correlation between false negatives of FDG-TEP staging in locally advanced cervical cancer and FIGO 2009 clinical staging system. A retrospective single-center cohort
- Authors:
- Boscher, Adrien
Bogart, Emilie
Benna, Mehdi
Pasquesoone, Camille
Hajj, Houssein El
Hudry, Delphine
Gauthier, Helene
Brochet, Julien
Chevalier-Evain, Valerie
Tinier, Florence Le
Leblanc, Eric
Deley, Marie Cecile Le
Narducci, Fabrice
Cordoba, Abel
Gomez, Carlos Martinez - Abstract:
- Abstract : Introduction/Background: Lymph node involvement in locally advanced cervical cancer impacts survival and defines radiation fields. False negatives (FN) of Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in the aortic region represent a limitation of this technique. It may lead to undertreatment of metastatic aortic lymph nodes. In selected cases, aortic lymph node staging can be considered to catch up the FN to tailor radiation fields. The aim was to analyze metastatic aortic lymph status according to FIGO 2009 classification and pelvic lymph node status. Methodology: From 01/2009 to 12/2019, we retrospectively reviewed all consecutive patients (pts) addressed for brachytherapy diagnosed with locally advanced cervical cancer FIGO 2009 stages IB2-IVa with negative PET-CT uptake in the aortic area and histologic lymph node involvement after surgical staging. Results: Of 178 pts who underwent surgical staging, metastatic aortic lymph nodes were found in 26 cases (FN rate=14, 6%). Among these 26 pts, 12 (46%) did not show pelvic TEP-CT uptake, while 14 (54%) did. FIGO 2009 stages was IB2-II for 5 pts (19%), stage III for 20 pts (77%) and stage IV for 1 pt (4%). When analyzing pts with metastatic pelvic nodes, determined with preoperative PET-CT and FIGO 2009 staging system, aortic involvement was found in 4/5 pts (80%) of stages IB2-II and 10/20 pts (50%) of stages III. Conclusion: Aortic lymph node dissection is helpful to optimizeAbstract : Introduction/Background: Lymph node involvement in locally advanced cervical cancer impacts survival and defines radiation fields. False negatives (FN) of Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in the aortic region represent a limitation of this technique. It may lead to undertreatment of metastatic aortic lymph nodes. In selected cases, aortic lymph node staging can be considered to catch up the FN to tailor radiation fields. The aim was to analyze metastatic aortic lymph status according to FIGO 2009 classification and pelvic lymph node status. Methodology: From 01/2009 to 12/2019, we retrospectively reviewed all consecutive patients (pts) addressed for brachytherapy diagnosed with locally advanced cervical cancer FIGO 2009 stages IB2-IVa with negative PET-CT uptake in the aortic area and histologic lymph node involvement after surgical staging. Results: Of 178 pts who underwent surgical staging, metastatic aortic lymph nodes were found in 26 cases (FN rate=14, 6%). Among these 26 pts, 12 (46%) did not show pelvic TEP-CT uptake, while 14 (54%) did. FIGO 2009 stages was IB2-II for 5 pts (19%), stage III for 20 pts (77%) and stage IV for 1 pt (4%). When analyzing pts with metastatic pelvic nodes, determined with preoperative PET-CT and FIGO 2009 staging system, aortic involvement was found in 4/5 pts (80%) of stages IB2-II and 10/20 pts (50%) of stages III. Conclusion: Aortic lymph node dissection is helpful to optimize radiation therapy fields in locally advanced cervical cancer. Pts with stages III and IV and those with stage Ib2-II and positive pelvic lymph seems to present the highest risk of occult aortic involvement. Aortic staging may be omitted in pts with stages Ib2-II without pelvic nodes as the risk of aortic involvement remains low. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 32(2022)Supplement 2
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 32(2022)Supplement 2
- Issue Display:
- Volume 32, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 32
- Issue:
- 2
- Issue Sort Value:
- 2022-0032-0002-0000
- Page Start:
- A48
- Page End:
- A48
- Publication Date:
- 2022-10-20
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2022-ESGO.106 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24569.xml